Triple-negative breast cancer comprises 15–20% of all breast canc...

18. Molecular Genetic Tools

Methods for Analyzing DNA

18. Molecular Genetic Tools

ANSWERS OPTIONS

BRCA1 gene mutation, estrogen receptor, progesterone receptor.

BRCA1 gene mutation, progesterone receptor, human epidermal growth factor receptor2 gene amplification.

BRCA1 gene mutation, estrogen receptor, BRCA2 gene mutation.

Estrogen receptor, progesterone receptor, human epidermal growth factor receptor2 gene amplification.

Triple-negative breast cancer comprises 15–20% of all breast cancer cases and affects women with a mutation in the BRCA1 gene more than other breast cancers. TNBC is breast cancer that lacks or shows low levels of: